Hearing and Cognition in Aging Adults

ConditionPresbycusis

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age45-50

SponsorUniversity Hospital, Toulouse

About this trial

This cohort study is expected to provide valuable insights into the complex interplay between auditory and cognitive functions and how they change over time. The results of this study will have important implications for the prevention, diagnosis, and treatment of age-related hearing and cognitive disorders

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Normal hearing (Pure Tone Audiometry < or = 20 dB)

Affiliation with a social security system

Disqualifiers

Individuals under guardianship, trusteeship or curators

History of neurological pathologies

Taking of psychotropic medication.

Trial population

Adult normal hearing subjects aged between 45 and 50 years old.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

auditory level
Diagnostic test
* Evaluation of auditory thresholds through audiometric tests. * Evaluation of speech comprehension in noise through a vocal audiometry test in noise (FraMatrix). * Evaluation of spatial auditory behavior and spatial precision using a spatial discrimination test (Minimum Audible Angle) and a static sound localization test in virtual reality.
cognitive level
Diagnostic test
* Evaluation of attention and short-term memory functions with verbal and non-verbal tasks: Digit Span Test and Reading Span Test. * Evaluation of inhibition capacities using the Stroop Test. * Evaluation of executive functions, visual attention, reasoning, and mental arithmetic using the Raven's Matrix test.
quality of life level
Diagnostic test
\- Evaluation of quality of live level via Speech, Spatial and Qualities of Hearing Scale (SSQ-12) and EuroQol-5D questionnaires.

Treatment groups

262 Participants

are divided into 1 treatment group

Group A: hearing subject3 interventions

Trial outcomes

Primary outcomes

Pure-ton audiometry

Pure-tone audiometry will be evaluated by collecting the threshold in air and bone conduction for both ears on each frequency tested (125-250-500-1000-2000-4000 and 8000 Hz), as well as the average hearing loss (MAP ) on all five frequencies.

Time frame

5 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Toulouse

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: